APA (7th ed.) Citation

Anna Lisa Ong-Lim, Georgi Shukarev, Mitzi Trinidad-Aseron, Delia Caparas-Yu, Astrid Greijer, Michel Duchene, . . . Jeanne-Marie Jacquet. (2022). Safety and immunogenicity of 3 formulations of a Sabin inactivated poliovirus vaccine produced on the PER.C6® cell line: A phase 2, double-blind, randomized, controlled study in infants vaccinated at 6, 10 and 14 weeks of age. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Anna Lisa Ong-Lim, et al. Safety and Immunogenicity of 3 Formulations of a Sabin Inactivated Poliovirus Vaccine Produced on the PER.C6® Cell Line: A Phase 2, Double-blind, Randomized, Controlled Study in Infants Vaccinated at 6, 10 and 14 Weeks of Age. Taylor & Francis Group, 2022.

MLA (9th ed.) Citation

Anna Lisa Ong-Lim, et al. Safety and Immunogenicity of 3 Formulations of a Sabin Inactivated Poliovirus Vaccine Produced on the PER.C6® Cell Line: A Phase 2, Double-blind, Randomized, Controlled Study in Infants Vaccinated at 6, 10 and 14 Weeks of Age. Taylor & Francis Group, 2022.